Literature DB >> 7885941

Why is catheter ablation less successful than surgery for treating ventricular tachycardia that results from coronary artery disease?

S M Blanchard1, G P Walcott, J M Wharton, R E Ideker.   

Abstract

Nearly 80% of patients with coronary artery disease who have map-directed surgery for control of ventricular tachycardias require no drug therapy to prevent recurrences, while fewer than 50% of patients undergoing catheter ablation have similar outcomes. Catheter ablation will fail if arrhythmogenic sites are incompletely ablated by lesions that are too small or too far away from the reentrant pathway or if all arrhythmogenic sites are not identified. The underlying assumptions used to guide site selection are that: (a) ventricular tachycardias arise from reentrant mechanisms; (b) monomorphic ventricular tachycardias with similar QRS morphologies arise from the same pathway; (c) the ventricular tachycardia initiated during the procedure represents the patient's spontaneous arrhythmia; (d) the endocardial site that should be ablated can be identified from cardiac activation maps produced during induced ventricular tachycardia or from ancillary techniques; and (e) the patient has only one or two reentrant pathways. Relying on incorrect assumptions may account for the difference in success rates. Patients may have similar appearing ventricular tachycardias that arise from different pathways, and the entire thin layer of viable tissue between the infarct and the endocardium may contain many reentrant pathways. Some ventricular tachycardias may arise from the myocardium away from the endocardium, while others may arise from the epicardium. Small lesions may not be large enough to eliminate all possible reentrant pathways. Catheter ablation may be less successful because the lesions are inadequate, the assumptions guiding the selection of arrhythmogenic tissue are incorrect, or all arrhythmogenic sites are not identified. The primary reason catheter ablation is less successful than surgery in the treatment of ventricular tachycardias is that catheter ablation does not ablate as much tissue as is removed by surgery. The success rate of catheter ablation probably can be improved if the amount of tissue ablated is increased.

Entities:  

Mesh:

Year:  1994        PMID: 7885941     DOI: 10.1111/j.1540-8159.1994.tb02382.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  13 in total

1.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  J Interv Card Electrophysiol       Date:  2020-10       Impact factor: 1.900

2.  Intracoronary arterial occlusion: a novel technique potentially useful for ablation of cardiac arrhythmias.

Authors:  T Y Hsia; M Billingham; R J Sung
Journal:  J Interv Card Electrophysiol       Date:  1997-02       Impact factor: 1.900

3.  Statistical analysis of signals from an intracavitary probe in a diseased heart.

Authors:  R A Malkin; J E Penzotti; S P Juhlin; T C Pilkington; R Plonsey
Journal:  Med Biol Eng Comput       Date:  1997-09       Impact factor: 2.602

4.  Role of orthotopic heart transplantation in the management of patients with recurrent ventricular tachyarrhythmias following myocardial infarction.

Authors:  J P Bourke; A Loaiza; G Parry; C Hilton; S Furniss; J Dark; J Forty
Journal:  Heart       Date:  1998-11       Impact factor: 5.994

5.  2019 HRS/EHRA/APHRS/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias.

Authors:  Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld
Journal:  Europace       Date:  2019-08-01       Impact factor: 5.214

6.  Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2005-09-01

7.  Nonsurgical transthoracic epicardial approach in patients with ventricular tachycardia and previous cardiac surgery.

Authors:  Eduardo Sosa; Mauricio Scanavacca; André D'Avila; José Antônio; Franchine Ramires
Journal:  J Interv Card Electrophysiol       Date:  2004-06       Impact factor: 1.900

8.  Simultaneous epicardial and endocardial substrate mapping and radiofrequency catheter ablation as first-line treatment for ventricular tachycardia and frequent ICD shocks in chronic chagasic cardiomyopathy.

Authors:  Benhur Davi Henz; Thais A do Nascimento; Cristiano de O Dietrich; Charles Dalegrave; Veruska Hernandes; Cezar E Mesas; Luiz R Leite; Claudio Cirenza; Samuel J Asirvatham; Angelo Amato Vincenzo de Paola
Journal:  J Interv Card Electrophysiol       Date:  2009-09-15       Impact factor: 1.900

9.  A novel catheter design for laser photocoagulation of the myocardium to ablate ventricular tachycardia.

Authors:  Alan Wagshall; George S Abela; Alok Maheshwari; Anoop Gupta; Russell Bowden; S K Stephen Huang
Journal:  J Interv Card Electrophysiol       Date:  2002-08       Impact factor: 1.900

10.  Clinical Management for Survivors of Sudden Cardiac Death.

Authors:  Michael R Lauer
Journal:  Perm J       Date:  2001
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.